Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1081–1104 of 1,285 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Model 2 Clear all

Conditions: Healthy
Interventions: tivozanib; Drug
Lead sponsor: AVEO Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Gestational Diabetes Mellitus in Pregnancy, Pregnancy, High Risk
Interventions: Enhanced First Trimester GDM Screening, Routine Gestational Diabetes Screening; Diagnostic Test
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Post-Traumatic Stress Symptoms, Problematic Use of Alcohol or Other Drugs
Interventions: Web-based Cognitive Behavioral Treatment; Behavioral
Lead sponsor: National Development and Research Institutes, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Buffalo, New York • Syracuse, New York

Conditions: Allergic Conjunctivitis
Interventions: Prednisolone Acetate 1%, Prednisolone Acetate 0.12%, Loteprednol Etabonate 0.2%, Placebo; Drug
Lead sponsor: ORA, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Intrauterine Growth Retardation, Prematurity
Interventions: Newborn Individualized Developmental Care; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 36 Weeks
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2002
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Autism, Autism Spectrum Disorder
Interventions: Early Start Denver Model, Standard community care; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 12 Months to 24 Months
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Hypertensive Disorders of Pregnancy (HDP)
Interventions: HEART at Home; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Massage
Interventions: Quantifiable Soft Tissue Manipulation (QSTM); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 106 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Healthy
Interventions: Transfusion of 7-day stored red blood cells, Transfusion of 28-day stored red blood cells, Transfusion of 42-day stored red blood cells; Biological
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Dyspnea, Lactic Acidosis, Muscle, Breathlessness, Exercise, Recovery
Interventions: High Velocity Therapy; Device
Lead sponsor: Vapotherm, Inc.; Industry
Eligibility: 18 Years to 30 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity
Interventions: Insulin human, Octreotide Acetate, Glucagon, Growth Hormone, Human, 20% D-glucose (aq), [6,6-2H2] D-glucose, [1-13C1] sodium acetate, Nestle BOOST Plus, KIND Bar, Harvard Apparatus PHD ULTRA CP syringe pump, Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer; Drug · Diagnostic Test · Dietary Supplement + 1 more
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Use Disorder
Interventions: NIATx; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Adolescent Idiopathic Scoliosis (AIS), Mental Health
Interventions: Aims to Decrease Anxiety and Pain Treatment (ADAPT); Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 10 Years to 19 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Caries
Interventions: 0 ppm F (placebo, negative control), 250 ppm F as NaF (dose-response control), 500 ppm F as NaF (dose-response control), 1100 ppm F as NaF (positive control); Drug
Lead sponsor: Domenick Zero; Other
Eligibility: 18 Years to 85 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Malaria
Interventions: MAM01 1.5 mg/kg, Placebo, MAM01 5 mg/kg, MAM01 10 mg/kg, MAM01 40 mg/kg, MAM01 450 mg, Control, MAM01 600 mg, MAM01 900 mg; Biological · Other
Lead sponsor: Gates Medical Research Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS), Hodgkins Lymphoma, Non-Hodgkins Lymphoma
Interventions: Administration of hyperbaric oxygen; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 17 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Pregnancy, HIV Infections, Sexually Transmitted Diseases
Interventions: CenteringPregnancy Plus (CP+), Usual care; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 14 Years to 21 Years · Female only
Enrollment: 1,233 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: New Haven, Connecticut • Boston, Massachusetts • New York, New York

Conditions: Hand Washing
Interventions: Organization Model, Data Feedback Model; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 1,624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cognition Disorders, Fatigue, Sleep Disorders, Other Complications of Bone Marrow Transplant
Interventions: quality-of-life assessment, questionnaire administration, management of therapy complications, cognitive assessment, educational intervention; Other · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Tobacco Cessation, Tobacco Abstinence, Tobacco Use, Tobacco Use Cessation, Tobacco Dependence
Interventions: Nicotine Replacement Therapy (NRT), Wellness Coaching; Drug · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Opioid Use Disorder, Dual Diagnosis, Housing Problems, Mental Disorder in Adolescence, Risk Behavior, Homelessness
Interventions: Motivational Interviewing/Community Reinforcement Approach (MI/CRA), Strengths-Based Outreach and Advocacy (SBOA ), Services as Usual (SAU); Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 14 Years to 24 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Columbus, Ohio

Conditions: Stage II Prostate Carcinoma
Interventions: CyberKnife radiosurgery; Radiation
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Washington, Virginia

Conditions: Neoplasms, Solid Tumors
Interventions: aza-TdC; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Bacterial Infections
Interventions: BestDose Computer Software; Device
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: Not listed
Enrollment: 263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects

Early Detection of Gestational Diabetes Mellitus in Pregnancy

Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care

Intensive Intervention for Toddlers With Autism (EARLY STEPS)

Postpartum Home Visiting (HEART at Home)

The Reproducibility and Consistency of Instrument-assisted Soft Tissue Manipulation

VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?

Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Expanding Medication-Assisted Therapies in Central Asia

Psychological Assessment of Scoliosis Patients Undergoing Surgical Management

Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

Increasing Evidence-based Clinical Practices in VA

Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessness

Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software